Tata Chemicals Limited

NSE:TATACHEM.NS

1120.25 (INR) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 154,210167,890125,171.2100,887.9102,523.7112,179.1102,696.9120,884.1145,596.8139,703.2133,059.6123,076.8138,060.6108,946.294,484.9121,533.159,816.858,09640,290.1
Cost of Revenue 82,14062,71030,155.726,795.823,081.725,020.720,993.144,707.276,509.672,558.865,244.560,065.875,971.891,966.477,063.5103,937.673,418.623,60618,264.9
Gross Profit 72,070105,18095,015.574,092.179,44287,158.481,703.876,176.969,087.267,144.467,815.163,01162,088.816,979.817,421.417,595.5-13,601.834,49022,025.2
Gross Profit Ratio 0.4670.6260.7590.7340.7750.7770.7960.630.4750.4810.510.5120.450.1560.1840.145-0.2270.5940.547
Reseach & Development Expenses 950303041.645.1364.3337.5349.6842.8600.4511.8151.50000000
General & Administrative Expenses 30,720910823.1631.7454.2351.1322.2348.5428.9434.4438.9381.65,057.700013,800.712,221.77,180.3
Selling & Marketing Expenses 22,6804,58022,046.717,681.718,382.123,187.820,942.322,805.129,176.827,942.525,877.623,674.216,749.20005,957.45,574.34,252.3
SG&A 53,4005,49022,869.818,313.418,836.323,538.921,264.523,153.629,605.728,376.926,316.524,055.821,806.900019,758.117,79611,432.6
Other Expenses 2,8602,180392.6666.5587.7532.878374.82,361.7-544.37,267.93,988.922,072.75,669.48,092.47,230.16,098.59,212.74,255.2
Operating Expenses 53,40075,88079,649.166,380.566,323.371,644.464,731.358,962.850,459.948,238.355,146.744,856.243,879.65,669.48,092.47,230.125,856.627,008.715,687.8
Operating Income 18,67030,17015,4908,115.513,210.212,513.716,972.517,214.118,627.318,906.112,668.418,154.818,209.211,209.69,3299,173.2-39,458.47,481.36,053.4
Operating Income Ratio 0.1210.180.1240.080.1290.1120.1650.1420.1280.1350.0950.1480.1320.1030.0990.075-0.660.1290.15
Total Other Income Expenses Net -11,050-2,7701,180-1,775.6-729.61,858.9-771.2-2,648.1-5,913.3-7,321-17,857.3-9,024.5-4,374.9-100.80-1,192.251,217.10-330.9
Income Before Tax 7,62027,40016,666.36,339.912,480.617,417.516,201.314,56612,71411,585.1-5,188.99,130.313,834.311,209.69,3299,173.211,758.77,481.36,006.5
Income Before Tax Ratio 0.0490.1630.1330.0630.1220.1550.1580.120.0870.083-0.0390.0740.10.1030.0990.0750.1970.1290.149
Income Tax Expense 3,8102,8802,664.81,977.72,196.53,469.2601.33,573.32,915.33,511.22,887.83,025.23,439.22,749.22,093.21,575.12,114.72,400.91,723.1
Net Income 2,68023,17012,5802,563.770,063.311,559.124,330.89,931.17,801.65,964.6-10,3204,00410,395.18,460.47,235.87,598.19,6445,080.44,283.4
Net Income Ratio 0.0170.1380.1010.0250.6830.1030.2370.0820.0540.043-0.0780.0330.0750.0780.0770.0630.1610.0870.106
EPS 10.5290.9549.3710.06275.0245.3795.5138.9830.2523.41-40.5115.7232.8826.125.6127.5943.5123.6219.91
EPS Diluted 10.5290.9549.3710.06275.0245.3795.5138.9830.2523.41-40.5115.7232.8826.125.6126.1938.5220.9317.8
EBITDA 28,47040,38026,670.516,126.820,329.123,428.123,05323,02321,794.322,27210,279.223,769.424,46015,921.713,796.815,784-36,320.110,220.18,177.8
EBITDA Ratio 0.1850.2410.2130.160.1980.2090.2240.190.150.1590.0770.1930.1770.1460.1460.13-0.6070.1760.203